NCT07239804

Brief Summary

The aim is to analyze long-term outcomes in a multicenter observational registry including patients undergoing atrial tachycardia rhythm control.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
2mo left

Started Jan 2024

Typical duration for all trials

Geographic Reach
1 country

5 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Jan 2024Aug 2026

Study Start

First participant enrolled

January 1, 2024

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

November 15, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 20, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Expected
Last Updated

November 20, 2025

Status Verified

November 1, 2025

Enrollment Period

2 years

First QC Date

November 15, 2025

Last Update Submit

November 18, 2025

Conditions

Keywords

Atrial tachycardia rhythm controlCardiovascular outcomesCatheter ablationElectrocardioversionStrokeCardiac hospitalizationMortality

Outcome Measures

Primary Outcomes (1)

  • Mortality, stroke and cardiovascular hospitalization

    From AT rhythm control through study completion, an average of 2 years

Study Arms (1)

Patients undergoing atrial tachycardia rhythm control

Patients undergoing catheter ablation and/or electrocardioversion for atrial tachycardia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing atrial tachycardia rhythm control

You may qualify if:

  • Patients undergoing atrial tachycardia rhythm control

You may not qualify if:

  • Follow-up \<30 days after atrial tachycardia rhythm control

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

EVK Düsseldorf

Düsseldorf, Germany

Location

Asklepios Hospital St. Georg

Hamburg, Germany

Location

University Hospital Hamburg-Eppendorf

Hamburg, Germany

Location

Municipal Clinical Center Karlsruhe

Karlsruhe, Germany

Location

University Hospital Münster

Münster, Germany

Location

Related Publications (3)

  • Jungen C, Akbulak R, Kahle AK, Eickholt C, Schaeffer B, Scherschel K, Dinshaw L, Muenkler P, Schleberger R, Nies M, Gunawardene MA, Klatt N, Hartmann J, Merbold L, Jularic M, Willems S, Meyer C. Outcome after tailored catheter ablation of atrial tachycardia using ultra-high-density mapping. J Cardiovasc Electrophysiol. 2020 Oct;31(10):2645-2652. doi: 10.1111/jce.14703. Epub 2020 Aug 11.

    PMID: 32748442BACKGROUND
  • Kahle AK, Jungen C, Scherschel K, Alken FA, Meyer C. Relationship Between Early and Late Recurrences After Catheter Ablation for Atrial Tachycardia in Patients With a History of Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2022 Jun;15(6):e010727. doi: 10.1161/CIRCEP.121.010727. Epub 2022 May 27. No abstract available.

    PMID: 35622433BACKGROUND
  • Brachmann J, Lewalter T, Kuck KH, Andresen D, Willems S, Spitzer SG, Straube F, Schumacher B, Eckardt L, Danilovic D, Thomas D, Hochadel M, Senges J. Long-term symptom improvement and patient satisfaction following catheter ablation of supraventricular tachycardia: insights from the German ablation registry. Eur Heart J. 2017 May 1;38(17):1317-1326. doi: 10.1093/eurheartj/ehx101.

    PMID: 28329395BACKGROUND

MeSH Terms

Conditions

StrokeAtrial Flutter

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesArrhythmias, CardiacHeart DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Christian Meyer, MD, MA

    EVK, Düsseldorf

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of the Division of Cardiology, Electrophysiology, Angiology, Intensive Care at the EVK Düsseldorf and Principal Investigator

Study Record Dates

First Submitted

November 15, 2025

First Posted

November 20, 2025

Study Start

January 1, 2024

Primary Completion

January 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

November 20, 2025

Record last verified: 2025-11

Locations